These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11758187)
1. [Experimental study on resistance to cisplatin and taxol in human ovarian cancer SKOV3ip1 multicellular aggregates]. Chen J; Feng Y; Zhou X Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):489-92. PubMed ID: 11758187 [TBL] [Abstract][Full Text] [Related]
2. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol]. Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643 [TBL] [Abstract][Full Text] [Related]
3. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Frankel A; Buckman R; Kerbel RS Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826 [TBL] [Abstract][Full Text] [Related]
5. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma. Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891 [TBL] [Abstract][Full Text] [Related]
6. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891 [TBL] [Abstract][Full Text] [Related]
7. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. Xing H; Wang S; Weng D; Chen G; Yang X; Zhou J; Xu G; Lu Y; Ma D Oncol Rep; 2007 Jan; 17(1):117-22. PubMed ID: 17143487 [TBL] [Abstract][Full Text] [Related]
8. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro. Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229 [TBL] [Abstract][Full Text] [Related]
9. [Apoptosis induced by cisplatin and verapamil or SDZ PSC 833 in human ovarian cell lines]. Liao M; Chen H; Shui H Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):101-4. PubMed ID: 11809110 [TBL] [Abstract][Full Text] [Related]
10. Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells. Dodier P; Piché A Gynecol Oncol; 2006 Feb; 100(2):254-63. PubMed ID: 16188300 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385 [TBL] [Abstract][Full Text] [Related]
12. [Impact of hypoxia on taxol-induced apoptosis in human ovarian cancer cell line A2780 and its mechanism]. Huang L; Ao QL; Li F; Xing H; Lu YP; Ma D Ai Zheng; 2005 Apr; 24(4):408-13. PubMed ID: 15820061 [TBL] [Abstract][Full Text] [Related]
13. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells. Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413 [TBL] [Abstract][Full Text] [Related]
14. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
15. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations. Yan XD; Li M; Yuan Y; Mao N; Pan LY Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060 [TBL] [Abstract][Full Text] [Related]
16. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines]. Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691 [TBL] [Abstract][Full Text] [Related]
17. Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells. Wang G; Shang HL; Xie Y; Xiao P; Li XJ; Lin TC; Li GY Chin Med J (Engl); 2005 Feb; 118(4):333-6. PubMed ID: 15740674 [No Abstract] [Full Text] [Related]
18. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model. Qamar L; Davis R; Anwar A; Behbakht K Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662 [TBL] [Abstract][Full Text] [Related]
19. [Alphavbeta 6 integrin inhibits cisplatin-induced apoptosis in ovarian cancer cell lines]. Wu XH; Li DX; Li L; Guo YH; Yang B; Shan BE Zhonghua Fu Chan Ke Za Zhi; 2004 Feb; 39(2):112-5. PubMed ID: 15059590 [TBL] [Abstract][Full Text] [Related]
20. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP]. Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]